Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,581,612
+$1,184,289 QoQ
Shares Held
624,844
-3.8% QoQ
Ownership
0.703%
of shares outstanding
% of Portfolio
19.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$21,089,112
PutShares
558,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Buckley Capital Advisors, LLC holds $23,581,612 across 1 Drug Manufacturers - Specialty & Generic name. LQDA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
624,844 | $23,581,612 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,581,612 | 624,844 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $21,089,112 | 558,800 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $22,397,323 | 649,386 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $20,252,528 | 587,200 | Put | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||